CMV RQ Bio-Enzabead Kit
510(k) K831343
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK831343 | Date8 Aug 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LFZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3175
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The CMV RQ Bio-Enzabead Kit is an Enzyme Linked Immunoabsorbent Assay (ELISA) for detecting cytomegalovirus (CMV) antibodies. This in vitro diagnostic device quantifies immunoglobulin (Ig) antibodies in human serum or plasma, aiding in the serological diagnosis of CMV infection. It employs enzyme-linked immunosorbent techniques to detect specific antibody responses, facilitating clinical assessment of exposure or immunity.
This kit is intended for use in microbiology laboratories under controlled conditions. Supplied as a single-use diagnostic reagent, it requires no sterilization beyond manufacturer-provided packaging. The device is classified as Class II under FDA regulation 866.3175 and was granted FDA 510(k) clearance (K831343) in 1983, with a Substantially Equivalent (SESE) determination. No MRI safety or reusable components are specified; storage follows standard laboratory protocols for immunoassay reagents.
Other devices from Litton Bionetics
Questions
AI-generated answers, 1 Oct 2026
What is the CMV RQ Bio-Enzabead Kit used for?
The CMV RQ Bio-Enzabead Kit is an enzyme-linked immunosorbent assay (ELISA) designed to detect and quantify immunoglobulin (Ig) antibodies against cytomegalovirus (CMV) in human serum or plasma. It helps clinicians assess whether a patient has been exposed to CMV or has developed immunity, supporting serological diagnosis in microbiology laboratories.
How is the CMV RQ Bio-Enzabead Kit supplied and prepared for use?
The kit is supplied as a single-use diagnostic reagent, meaning each kit is intended for one-time use only. No additional sterilization beyond the manufacturer-provided packaging is required. It is designed for use in controlled microbiology laboratory settings, where standard immunoassay protocols apply.
Is the CMV RQ Bio-Enzabead Kit sterile or reusable?
The kit is not intended for reuse and is supplied in sterile packaging as a single-use diagnostic reagent. Sterility is maintained by the manufacturer, and no further sterilization steps are necessary before use.
What regulatory pathway does the CMV RQ Bio-Enzabead Kit follow?
The CMV RQ Bio-Enzabead Kit was granted FDA 510(k) clearance under the Traditional pathway in 1983 (K831343) with a Substantially Equivalent (SESE) determination. It is classified as a Class II medical device under FDA regulation 866.3175, specifically for enzyme-linked immunosorbent assays related to CMV detection.
How should the CMV RQ Bio-Enzabead Kit be stored?
Storage follows standard laboratory protocols for immunoassay reagents. The kit should be stored in a controlled environment, protected from extreme temperatures, moisture, and direct light, to maintain its integrity and performance. Always refer to the manufacturer’s instructions for precise storage guidelines.